BRAF inhibitors and their immunological effects in malignant melanoma
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2022.2044796
Abstract: ABSTRACT Introduction The treatment of cutaneous melanoma has been revolutionized by the development of small-molecule inhibitors targeting the MAPK pathway, including inhibitors of BRAF (BRAFi) and MEK (MEKi), and immune checkpoint blockade antibodies, occurring in… read more here.
Keywords: melanoma; inhibitors immunological; braf inhibitors; effects malignant ... See more keywords